| abstract |
Disclosed are compounds of formula I, pharmaceutically acceptable acid or base addition salts thereof, and uses thereof. These compounds and their pharmaceutically acceptable acid or base addition salts prepare drugs that modulate estrogen-related receptors (ERR), such as high blood fat, fatty liver, hyperglycemia, diabetes, obesity, etc. Used to treat various metabolic disorders. The definition of the functional group of the formula is described in the specification. |